Belgium · Venture startup

Who invested in Ncardia

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$72Mraised across 2 rounds since 2017, from 2 sources

$12MSeries B$60MVenture

Latest round: Venture, $60MNov 2021
Step-upi: 5×
Investors: 7

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2018201920202021

$12MSeries B$60MVenture

First round: Series B, $12M
Biggest round: $60M
Between rounds: 3.9 years

The rounds

Nov 2021
Venture$60M2 new
- EISMEA
- InnovationQuarter
Source recorded
Nov 2017
Series B$12M5 new
- S.R.I.W.
- SFPI-FPIM
- Sambrinvest
- Vesalius
- pimède/ InnovationQuarter
Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2017Venture2021EISMEA

InnovationQuarter

S.R.I.W.

SambrinvestSFPI-FPIMpimède/ InnovationQuarterVesalius

Everyone who backed them

EISMEAInvestment firm1round

InnovationQuarterGovernment1round

S.R.I.W.Government1round

SambrinvestVC firm1round

SFPI-FPIMVC firm1round

pimède/ InnovationQuarterno record of our own yet1round

Vesaliusno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Ncardia as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

EpimèdeGrowth equityPer its own site